These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3488474)

  • 1. [Osteocalcin (BGP) values in postmenopausal osteoporosis before and after treatment with calcitonin].
    Rico H; Cabranes JA; Núñez-Torrón M; Higueras JC; Hernández ER
    Med Clin (Barc); 1986 May; 86(19):791-3. PubMed ID: 3488474
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of serum osteocalcin and of the histomorphometric evaluation of iliac biopsy in postmenopausal osteoporosis].
    Delmas PD; Brown JP; Malaval L; Edouard C; Chapuy MC; Meunier PJ
    Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):581-4. PubMed ID: 6335924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis.
    Zerwekh JE; Sakhaee K; Pak CY
    J Clin Endocrinol Metab; 1985 Mar; 60(3):615-7. PubMed ID: 3871787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis.
    Caniggia A; Nuti R; Galli M; Loré F; Turchetti V; Righi GA
    Calcif Tissue Int; 1986 Jun; 38(6):328-32. PubMed ID: 3089554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum osteocalcin in the treatment of senile osteoporosis with anabolic steroids. Further evidences for a new marker of bone formation.
    Cantatore FP; Carrozzo M; D'Amore M; Pipitone V
    Clin Rheumatol; 1986 Dec; 5(4):535-6. PubMed ID: 3493111
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.
    Delmas PD; Wahner HW; Mann KG; Riggs BL
    J Lab Clin Med; 1983 Oct; 102(4):470-6. PubMed ID: 6604769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for the use of calcitonin in postmenopausal osteoporosis.
    Avioli LV
    Ann Chir Gynaecol; 1988; 77(5-6):224-8. PubMed ID: 3076049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long term treatment of osteoporosis with thyrocalcitonin. Apropos of 7 cases].
    Bloch-Michel H; Milhaud G; Coutris G; Waltzing P; Charret A; Morin Y; Verger D; Dussart N
    Rev Rhum Mal Osteoartic; 1970 Oct; 37(10):629-38. PubMed ID: 5482813
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a long-term treatment with the aminosuberic analog of eel calcitonin on osteocalcin in Paget's disease.
    Caniggia A; Nuti R; Galli M; Turchetti V; Righi G
    Panminerva Med; 1987; 29(1):1-5. PubMed ID: 3496574
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
    Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
    Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of postmenopausal and senile osteoporosis with synthetic salmon calcitonin. A clinical study].
    Salvini S; Nicolazzo F; Farina P; Martelli G
    Clin Ter; 1987 Jun; 121(6):471-7. PubMed ID: 2973883
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women.
    Johansen JS; Riis BJ; Delmas PD; Christiansen C
    Eur J Clin Invest; 1988 Apr; 18(2):191-5. PubMed ID: 2968266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1980 May; 22(11):45-6. PubMed ID: 7374621
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of postmenopausal osteoporosis.
    Chesnut CH
    Compr Ther; 1984 Jul; 10(7):41-7. PubMed ID: 6744804
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of postmenopausal and senile osteoporosis.
    Riggs BL
    J Ark Med Soc; 1974 Mar; 70(10):317-22. PubMed ID: 4274387
    [No Abstract]   [Full Text] [Related]  

  • 16. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum osteocalcin radioimmunoassay in bone diseases.
    Galli M; Nuti R; Franci B; Righi G; Martorelli MT; Turchetti V; Caniggia M
    Ric Clin Lab; 1985; 15(3):253-7. PubMed ID: 3878567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basal serum osteocalcin in diseases associated with changes in bone metabolism].
    León M; Larrodera L; Solís JA; Hawkins F
    Med Clin (Barc); 1987 Jan; 88(3):90-2. PubMed ID: 3493401
    [No Abstract]   [Full Text] [Related]  

  • 19. [Calcitonin test].
    Zorzi R; Pescatori E
    Chir Ital; 1986 Jun; 38(3):321-5. PubMed ID: 3791535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcitonin deficiency in postmenopausal osteoporosis].
    Galán Galán F; Pérez Cano R; Rodríguez R; Vargas B; Jiménez Rubio-Manzanares A; Aramburu Bodas O; Garrido Peralta M
    Med Clin (Barc); 1985 Jul; 85(6):221-4. PubMed ID: 4033282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.